Amyloid precursor protein regulates migration and metalloproteinase gene expression in prostate cancer cells |
| |
Authors: | Toshiaki Miyazaki Kazuhiro Ikeda Kuniko Horie-Inoue Satoshi Inoue |
| |
Affiliation: | 1. Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical University, Saitama 350-1241, Japan;2. Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan;3. Department of Anti-Aging Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan |
| |
Abstract: | Amyloid precursor protein (APP) is a type I transmembrane protein, and one of its processed forms, β-amyloid, is considered to play a central role in the development of Alzheimer’s disease. We previously showed that APP is a primary androgen-responsive gene in prostate cancer and that its increased expression is correlated with poor prognosis for patients with prostate cancer. APP has also been implicated in several human malignancies. Nevertheless, the mechanism underlying the pro-proliferative effects of APP on cancers is still not well-understood. In the present study, we explored a pathophysiological role for APP in prostate cancer cells using siRNA targeting APP (siAPP). The proliferation and migration of LNCaP and DU145 prostate cancer cells were significantly suppressed by siAPP. Differentially expressed genes in siAPP-treated cells compared to control siRNA-treated cells were identified by microarray analysis. Notably, several metalloproteinase genes, such as ADAM10 and ADAM17, and epithelial–mesenchymal transition (EMT)-related genes, such as VIM, and SNAI2, were downregulated in siAPP-treated cells as compared to control cells. The expression of these genes was upregulated in LNCaP cells stably expressing APP when compared with control cells. APP-overexpressing LNCaP cells exhibited enhanced migration in comparison to control cells. These results suggest that APP may contribute to the proliferation and migration of prostate cancer cells by modulating the expression of metalloproteinase and EMT-related genes. |
| |
Keywords: | APP, amyloid precursor protein EMT, epithelial&ndash mesenchymal transition siRNA, small interfering RNA PVDF, polyvinylidene difluoride DMEM, Dulbecco&rsquo s modified eagle medium ADAM, a disintegrin and metalloproteinase ADAM10, ADAM metallopeptidase domain 10 ADAM17, ADAM metallopeptidase domain 17 CDH1, cadherin 1 VIM, vimentin SNAI1, snail family zinc finger 1 SNAI2, snail family zinc finger 2 GAPDH, glyceraldehyde-3-phosphate dehydrogenase |
本文献已被 ScienceDirect 等数据库收录! |
|